Medical Director, Clinical Development – MRD Portfolio (Solid Tumors)

Job Summary

The Medical Director, Clinical Development – MRD Portfolio is a physician scientific leader responsible for shaping and executing the clinical development strategy for Labcorp Oncology's minimal residual disease (MRD) portfolio across solid tumors. This individual serves as the medical lead for the development, validation, and clinical adoption of MRD and circulating tumor DNA (ctDNA)-based technologies, advancing precision oncology through innovative molecular diagnostics that improve patient outcomes across the cancer care continuum.

Job Responsibilities

• Serve as the clinical development lead for Labcorp Oncology's MRD portfolio across solid tumors, providing strategic medical leadership for evidence generation, product development, and clinical adoption initiatives.
• Develop and execute clinical development strategies supporting MRD and ctDNA-based technologies across multiple tumor types, disease settings, and clinical applications.
• Lead the medical design and clinical oversight of evidence-generation programs that establish the clinical validity, clinical utility, and health economic value of MRD testing.
• Drive alignment across internal stakeholders involved in clinical studies, evidence generation, and product development activities.
• Translate emerging clinical data into actionable recommendations that inform portfolio strategy, indication expansion, product development, and clinical adoption.
• Serve as the senior clinical subject matter expert for MRD technologies and applications across the oncology portfolio.
• Support investigator-initiated studies, strategic research collaborations, and real-world evidence programs that expand the evidence base supporting MRD testing.
• Provide medical leadership for the MRD portfolio throughout the product lifecycle, from concept development through commercialization and lifecycle management.
• Define clinical evidence requirements, intended use populations, clinical claims, validation strategies, and evidence-generation priorities necessary to support product adoption and clinical implementation.
• Partner with R&D, product, and innovation teams to guide assay development, biomarker strategies, and next-generation technology initiatives.
• Evaluate competitive technologies, emerging biomarkers, and evolving standards of care to inform portfolio priorities and future investment decisions.
• Act as the primary medical advisor for MRD-related portfolio strategy and indication expansion opportunities.
• Partner with market access teams to develop and execute evidence-generation strategies supporting payer coverage, reimbursement, and health-system adoption.
• Provide medical leadership for studies designed to demonstrate clinical utility, impact on physician decision-making, patient outcomes, and economic value.
• Support interactions with payers, policy stakeholders, and guideline organizations by communicating the clinical rationale and value proposition of MRD testing.
• Contribute to strategies supporting inclusion of MRD testing within clinical practice guidelines, treatment pathways, and value-based care models.
• Ensure clinical development priorities and evidence-generation plans align with reimbursement, market access, and adoption objectives.
• Build and maintain strategic relationships with leading oncology investigators, academic medical centers, cooperative groups, professional societies, and industry partners.
• Serve as the physician lead for external scientific collaborations, investigator engagement, and evidence-generation partnerships supporting MRD technologies.
• Influence the evolution of MRD clinical applications through engagement with key opinion leaders, scientific experts, and research organizations.
• Represent Labcorp Oncology as a recognized scientific expert at congresses, advisory boards, investigator meetings, and external scientific forums.
• Engage key opinion leaders to support clinical development strategy, evidence generation, and long-term portfolio planning.
• Provide medical leadership and post-launch support for MRD products, including interpretation of clinical evidence, management of complex clinical questions, and support for appropriate clinical implementation.
• Serve as a clinical resource for healthcare providers regarding MRD testing and integration of results into patient management.
• Provide medical expertise and scientific guidance for educational initiatives supporting MRD adoption across solid tumors, including tumor boards, webinars, educational programs, and scientific exchange activities.
• Partner with medical affairs, commercial, and marketing teams to develop scientifically accurate and clinically meaningful educational content.
• Lead publication planning and support development of manuscripts, abstracts, presentations, congress submissions, and peer-reviewed publications.
• Maintain scientific rigor and ensure evidence is effectively communicated to diverse clinical, scientific, and payer audiences.
• Serve as the clinical development leader for the MRD portfolio, driving strategy and execution through scientific expertise, influence, and cross-functional collaboration rather than through direct people management.
• Align diverse stakeholders around shared clinical development priorities, evidence-generation plans, and portfolio objectives.
• Provide expert guidance to clinical, scientific, operational, and commercial colleagues supporting MRD initiatives.
• Influence organizational decision-making through scientific insight, clinical expertise, and strategic recommendations.
• Contribute to the development of clinical development processes, best practices, and organizational capabilities that support growth of Labcorp Oncology's precision oncology portfolio.
• Mentor colleagues and provide scientific guidance to project teams, medical affairs partners, and other stakeholders as appropriate.
• Collaborate with leaders and stakeholders across Medical Affairs, Clinical Development, Operations, Biostatistics, Regulatory Affairs, Market Access, Commercial, Legal, Compliance, and Research & Development.
• Lead cross-functional discussions regarding clinical development strategy, evidence-generation priorities, portfolio investments, and indication expansion opportunities.
• Support regulatory submissions and interactions through clinical expertise, scientific rationale, and interpretation of evidence.
• Partner with commercial and market access teams to ensure clinical evidence generation aligns with customer, payer, and healthcare system needs.
• Monitor emerging scientific, clinical, technological, and competitive developments to inform strategic decision-making and future portfolio direction.